April 06, 2023
The Company has received notification from Vulpes Investment Management Pte Ltd ("Vulpes") that on 4 and 5 April 2023 it purchased, respectively, 14,766 and 100,000 ordinary shares of 1p in the capital of the Company ("Ordinary Shares") at a price of 4p per Ordinary Share (the “Purchase”). Following the Purchase, Vulpes has a total direct and indirect interest in 67,589,772 Ordinary Shares, equivalent to 22.89% of Proteome Sciences' total issued share capital.